Diagnostic performance of Oncuria™, a urinalysis test for bladder cancerYosuke Hirasawa, Hideki Furuya, Ian Pagano et al.|Journal of Translational Medicine|2021Cited by 54
Serum C-reactive Protein Level Predicts Overall Survival for Clear Cell and Non-Clear Cell Renal Cell Carcinoma Treated with Ipilimumab plus NivolumabYusuke Yano, Haruhito Azuma, Shutaro Yamamoto et al.|Cancers|2022Cited by 21
Predicting time to castration resistance with androgen-receptor signaling inhibitors in hormone-sensitive prostate cancer: data from ULTRA-Japan ConsortiumTaizo Uchimoto, Haruhito Azuma, Kengo Iwatsuki et al.|International Journal of Clinical Oncology|2024Cited by 12
C-Reactive Protein-Albumin Ratio Predicts Objective Response to Enfortumab Vedotin in Metastatic Urothelial CarcinomaTaizo Uchimoto, Haruhito Azuma, Takuya Matsuda et al.|Targeted Oncology|2024Cited by 12
Durable Response to Enfortumab Vedotin Compared to Re-challenging Chemotherapy in Metastatic Urothelial Carcinoma After Checkpoint InhibitorsTaizo Uchimoto, Haruhito Azuma, Shuya Tsuchida et al.|Targeted Oncology|2024Cited by 9